As part of the Black History outreach, staff from the Rochester and Finger Lakes region chapter met Friday for a community ...

The reassessment of Leqembi’s safety data follows the agency’s previous recommendation of the drug for use in the EU.

Researchers Create New Guidelines to Diagnose Common Memory Disorder Frequently Mistaken for Alzheimer's Disease Jan. 22, 2025 — New guidelines will help doctors identify patients with a common ...

Feb. 6, 2025 — A research team has discovered that the two key pathological hallmarks of Alzheimer's -- tau protein and beta-amyloid -- affect brain circuits in distinct yet synergistic ways ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

As of May 2023, the Azure Portal experience (accelerator) of the ALZ Reference Implementation (RI), will not include the "Platform DevOps and automation" section anymore. Consequently, users ...

Ways to reduce the risk of developing dementia include making positive lifestyle changes such as eating healthier and ...

Cobenfy, the main asset acquired through Bristol Myers’ $14 billion purchase of Karuna, had $10 million in sales in the fourth quarter and around 1,000 prescriptions weekly by late January.

Early onset familial Alzheimer disease (eFAD) is hereditary and marked by Alzheimer disease symptoms that appear at an unusually early age. Symptoms can start in a person's thirties, forties, and ...

Clinigen, the global speciality pharmaceutical services group, and Essential Pharma, an international specialty pharmaceutical group, today announced an expansion of their JAPAC collaboration, aimed ...

JOTROL is designed to overcome the historical challenges of resveratrol by significantly enhancing bioavailability while minimizing gastrointestinal side effects. The upcoming Phase 2a trial will ...